REG - ConvaTec Group PLC - Holding(s) in Company

ConvaTecAnnouncement

08/05/2018 10:55

2018-05-08T09:55:01.04Zreuters.comtag:reuters.com,2018-05-08:newsml_RSH3574Na:13TXT
This file is provided for EAP sample purposes only; it's structure and detail are subject to change, and should not be used as a definitive reference for actual development and processing.2018-05-08T09:55:01.04Z2018-05-08T09:55:01.04Z____UCDP:parsn_lse_10.54.4.69_1.2.37235:2019-06-08T09:55:01.040Z3RSH3574NaREG - ConvaTec Group PLC  - Holding(s) in CompanyHealthcare (TRBC level 1)Pharmaceuticals & Medical Research (TRBC level 2)LEGACY: Pharmaceuticals (TRBC level 3)LEGACY: Generic & Specialty Pharmaceuticals (TRBC)Proprietary & Advanced Pharmaceuticals (TRBC level 5)Pharmaceuticals (TRBC level 4)Western EuropeUnited KingdomEuropeSuggested SourcesNews AnnouncementsRegulatory Corporate News AnnouncementsCompany NewsEurope daily earnings hits & missesConvaTec Group PLC








RNS Number : 3574N
ConvaTec Group PLC
08 May 2018
 

TR-1: Standard form for notification of major holdings
 




NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i










1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:


CONVATEC GROUP PLC

(LEI: 213800LS272L4FIDOH92)




1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)




Non-UK issuer








2. Reason for the notification (please mark the appropriate box or boxes with an "X")




An acquisition or disposal of voting rights


X




An acquisition or disposal of financial instruments








An event changing the breakdown of voting rights








Other (please specify)iii:








3. Details of person subject to the notification obligationiv




Name


NORDIC CAPITAL VI LIMITED
NORDIC CAPITAL VII LIMITED




City and country of registered office (if applicable)


26 Esplanade, St Helier, Jersey JE2 3QA




4. Full name of shareholder(s) (if different from 3.)v




Name


CIDRON HEALTHCARE TOPCO LIMITED
CIDRON HEALTHCARE CO-INVEST LIMITED
CIDRON HEALTHCARE CO-INVEST II LIMITED




City and country of registered office (if applicable)


26 Esplanade, St Helier, Jersey JE2 3QA




5. Date on which the threshold was crossed or reachedvi:


08/05/2018




6. Date on which issuer notified (DD/MM/YYYY):


08/05/2018




7. Total positions of person(s) subject to the notification obligation








% of voting rights attached to shares (total of 8. A)


% of voting rights through financial instruments

(total of 8.B 1 + 8.B 2)


Total of both in % (8.A + 8.B)


Total number of voting rights of issuervii




Resulting situation on the date on which threshold was crossed or reached


0%


N/A


0%


1,951,850,599




Position of previous notification (if
applicable)


7.34%


N/A


7.34%

















 




8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii




A: Voting rights attached to shares




Class/type of

shares
ISIN code (if possible)


Number of voting rightsix


% of voting rights




Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)


Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)


Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)


Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)




ORDINARY SHARES OF £0.10 EACH
 
GB00BD3VFW73


0


0


0


0
















































SUBTOTAL 8. A


0


0%




 
 




B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))




Type of financial instrument


Expiration

datex


Exercise/

Conversion Periodxi


Number of voting rights that may be acquired if the instrument is
exercised/converted.


% of voting rights




N/A








































































SUBTOTAL 8. B 1












 
 




B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))




Type of financial instrument


Expiration

datex


Exercise/

Conversion Period xi


Physical or cash
settlementxii


Number of voting rights


% of voting rights




N/A
























































































SUBTOTAL 8.B.2












 
 
 
















 




9. Information in relation to the person subject to the notification obligation (please mark the
applicable box with an "X")




Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii








Full chain of controlled undertakings through which the voting rights and/or the

financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)


X




Namexv


% of voting rights if it equals or is higher than the notifiable threshold


% of voting rights through financial instruments if it equals or is higher than the notifiable threshold


Total of both if it equals or is higher than the notifiable threshold




See chain of control described in box 11 (Additional Information) below.
 
No entity in the chain of controlled undertakings now holds shares in the Issuer.


N/A


N/A


N/A








 


 


 








 


 


 






















































































































10. In case of proxy voting, please identify:




Name of the proxy holder


N/A




The number and % of voting rights held


N/A




The date until which the voting rights will be held


N/A










11. Additional informationxvi




Nordic Capital VI Limited is the General Partner of Nordic Capital VI Alpha, L.P. and Nordic Capital VI Beta, L.P. (Fund VI) and is responsible for managing Fund VI.
 
Nordic Capital VII Limited is the General Partner of Nordic Capital VII Alpha, L.P. and Nordic Capital VII Beta, L.P. (Fund VII) and is responsible for managing Fund VII.
 
Fund VI and Fund VII hold shares in Cidron Healthcare Topco Limited (Topco). Topco in turn holds one management share in each of Cidron Healthcare Co-invest Limited and Cidron Healthcare Co-invest II Limited.











 




Place of completion


St Helier, Jersey JE2 3QA




Date of completion


8 May 2018








 




Annex: Notification of major holdings (to be filed with the FCA only)










A: Identity of the person subject to the notification obligation




Full name (including legal form for legal entities)


NORDIC CAPITAL VI LIMITED
NORDIC CAPITAL VII LIMITED




Contact address (registered office for legal entities)


26 Esplanade, St Helier, Jersey JE2 3QA




E-Mail


Jean.lecreurer@nordiccapital.je




Phone number / Fax number


+ 44 1534 605103




Other useful information
(at least legal representative for legal persons)


Contact name: Jean Le Creurer














B: Identity of the notifier, if applicable




Full name








Contact address








E-Mail








Phone number / Fax number








Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)














C: Additional information















 
 
Please send the completed form together with this annex to the FCA at the following email
address: Majorshareholdings@fca.org.uk. Please send in Microsoft Word format if possible.
 
 



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEANSPESAPEEF